Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-26 @ 2:12 AM
Study NCT ID:
NCT07105592
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2025-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-21
First Submit QC Date:
None
Study First Post Date:
2025-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-04
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL